These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effects of inhibition of the maternal renin-angiotensin system on maternal and fetal responses to drainage of fetal fluids. Lumbers ER, Bernasconi C, Burrell JH. Can J Physiol Pharmacol; 1996 Aug; 74(8):973-82. PubMed ID: 8960388 [Abstract] [Full Text] [Related]
6. Effect of valsartan and captopril in rabbit carotid injury. Possible involvement of bradykinin in the antiproliferative action of the renin-angiotensin blockade. Feng TC, Ying WY, Hua RJ, Ji YY, de Gasparo M. J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1):19-24. PubMed ID: 11881060 [Abstract] [Full Text] [Related]
11. A dynamic comparative study concerning the effects of angiotensin-converting enzyme inhibitors and aldosterone receptor blockers on the fibrinolytic system. Usalan C, Buyukhatipoglu H. Clin Appl Thromb Hemost; 2008 Apr; 14(2):203-9. PubMed ID: 18372278 [Abstract] [Full Text] [Related]
13. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat. Erman A, Veksler S, Gafter U, Boner G, Wittenberg C, van Dijk DJ. J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251 [Abstract] [Full Text] [Related]
14. Differential effects of oral losartan and enalapril on local venous and systemic pressor responses to angiotensin I and II in healthy men. Goldberg MR, de Mey C, Wroblewski JM, Li Q, Schroeter V, Belz GG. Clin Pharmacol Ther; 1996 Jan; 59(1):72-82. PubMed ID: 8549037 [Abstract] [Full Text] [Related]
15. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat. Uhlenius N, Vuolteenaho O, Tikkanen I. J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129 [Abstract] [Full Text] [Related]
16. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950. Anderson IK, Drew GM. Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286 [Abstract] [Full Text] [Related]
17. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR. Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [Abstract] [Full Text] [Related]
18. The effects of angiotensin-II on lipolysis in humans. Townsend RR. Metabolism; 2001 Apr; 50(4):468-72. PubMed ID: 11288044 [Abstract] [Full Text] [Related]
19. Attenuation of tissue P-selectin and MCP-1 expression and intimal proliferation by AT(1) receptor blockade in hyperlipidemic rabbits. Chen HJ, Li DY, Saldeen T, Phillips MI, Mehta JL. Biochem Biophys Res Commun; 2001 Mar 30; 282(2):474-9. PubMed ID: 11401483 [Abstract] [Full Text] [Related]
20. Vascular angiotensin-converting enzyme activity in cholesterol-fed rabbits: effects of enalapril. Hoshida S, Nishida M, Yamashita N, Igarashi J, Aoki K, Hori M, Kuzuya T, Tada M. Atherosclerosis; 1997 Apr 30; 130(1-2):53-9. PubMed ID: 9126648 [Abstract] [Full Text] [Related] Page: [Next] [New Search]